ArcticZymes R2D LigaseTM
ArcticZymes R2D LigaseTM
ArcticZymes RNA to DNA Ligase (ArcticZymes R2D LigaseTM) is the first ligase on the market that is able to ligate DNA to 5’-phosphorylated ends of RNA in the presence of a DNA template positioning the joinable ends. With its unique substrate specificity, ArcticZymes R2D Ligase allows the development of new technologies in molecular biology research, diagnostics, and manufacturing.
https://arcticzymes.com/products/enzymes/azt-r2d-ligase/
ArcticZymes RNA to DNA Ligase (ArcticZymes R2D LigaseTM) is the first ligase on the market that is able to ligate DNA to 5’-phosphorylated ends of RNA in the presence of a DNA template positioning the joinable ends. With its unique substrate specificity, ArcticZymes R2D Ligase allows the development of new technologies in molecular biology research, diagnostics, and manufacturing.
https://arcticzymes.com/products/enzymes/azt-r2d-ligase/
JosefK
30.11.2022 kl 17:25
520
Hvis du vil vite, spurte jeg om det på Q1. Du finner det ca på 47 min:
https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20220428_14
Og om du lar den gå helt til slutten, outliner jethro litt om hvordan salgsutviklingen går på generelt grunnlag for de nye produktene. Han går også langt i å forklare hvordan utviklingen vil bli etter 2025, eller etter at 350 mill omsetningsmålet er nådd.
Jane Theaker liker R2D. Nå er hun inhabil så det holder, men selskapet hun jobber for er en typisk startup. Gi det litt tid.